Summary This study was undertaken to investigate the pathways involved in the interleukin 2 (IL-2)-driven growth of tumour-infiltrating lymphocytes (TILs). For 
Nowadays, data regarding the ability of TILs to control tumour growth have been extensively provided, but the mechanisms accounting for their proliferation in vitro and possibly in vivo have not been definitively investigated (Kawakami et al., 1988; Yagita et al., 1989; Shimuzu et al., 1991) .
IL-2 is a cytokine that plays a key role in T-cell proliferation (Robb, 1984; Smith, 1988) , mediating several functions by means of binding to specific surface IL-2 receptors (IL2Rs) , Waldmann, 1991 . Three forms of IL-2Rs are distinguishable on the basis of the affinity for their ligand: low-, intermediate-and high-affinity IL-2Rs. Different combinations of three distinct chains, the ax (p55), p (p75) and (p64) chains, form the three different classes of IL-2 receptors (Wang & Smith, 1987; Waldmann, 1991; Hatakeyama et al., 1989a; Tsudo et al., 1990; Takeshita et al., 1992; Arima et al., 1992; Voss et al., 1993; Noguchi et al., 1993) . While low-affinity receptors contain IL-2Roa, but not IL-2RP or IL-2Ry, intermediate-affinity IL-2Rs contain the Pand 'y-chains, but not the ax-chain. High-affinity receptors are formed from all three subunits. Monoclonal antibodies (MAbs) specifically recognising p55 and p75 IL-2Rs have been produced (Uchiyama et al., 1981; Takeshita et al., 1989; Tsudo et al., 1989) , thus allowing the characterisation of IL-2Rs on different cell types. The effects of IL-2 on cells equipped with specific receptors are likely to be mediated by the p75 IL-2Rs rather than by the p55 chain (Robb & Greene, 1987; Wang & Smith, 1987) .
This study was undertaken to analyse the mechanisms through which In nine of the 12 patients (nos. 1 to 9 in Table I ), TIL cultures were expanded in the presence of IL-2 for 2 days and restimulated with phytohaemaoagglutinin (PHA) (0.1 jig ml-) and irradiated feeders (normal PBL). Twelve hours after restimulation, medium was almost completely removed from the wells and was replaced with RPMI-1640 containing IL-2 alone. All studies were performed 14-18 days after restimulation. In three of the 12 patients (nos. 10 to 12 in Br. J. Cancer (1994) , 69, [1046] [1047] [1048] [1049] [1050] [1051] '." Macmillan Press Ltd., 1994 (Table  I) , while the killing of NK-sensitive targets at the 20:1 effector/target ratio was variable.
In four patients (Table II; two subjects with lung cancer and two patients with colorectal cancer), freshly isolated TILs were obtained following digestion of tumour specimens in RPMI-1640 medium supplemented with 10% FCS, 0.1% collagenase type IV (Sigma, St Louis, MO, USA), 0.002% DNAse type 1 (Sigma) and 0.01% hyaluronidase type V (Sigma) for 1-2 h at 37°C. Cell suspensions containing both TILs and tumour cells were washed and passed through a surgical gauze. TILs were purified by rosetting the cell suspension with neuroaminidase (Sigma)-treated SRBCs followed by repeated Ficoll/Hypaque gradient separations as previously described in detail (Trentin et al., 1990a) . Cell populations obtained using this procedure comprised TILs and tumour cell populations. More than 90% of cells were viable as judged by the trypan blue exclusion test. The phenotypic analysis of freshly isolated TILs is reported in Table II. Northern blot analysis Total cellular RNA was extracted from 107 TIL lines after lysis with 4 M guanidine isothiocyanate and by centrifugation through a 5.7 M caesium chloride gradient. A 10 gg aliquot of each sample was denatured at 65°C for 10 min in an electrophoresis buffer (20mM morpholinopropane sulphonic acid, 6.5% formaldehyde, 50% formamide, 0.05 mg ml-' Monoclonal antibodies andflow cytometry analysis TILs were studied for the expression of cell-surface antigens with direct two-colour analysis using FITC-conjugated and phycoerythrin-conjugated MAbs using flow cytometric analysis (FACScan, Becton Dickinson) as previously described (Trentin et al., 1990b) . To characterise the expression of IL-2R on TILs, before performing the phenotypical study, cells were washed in 40 mM citrate containing 140 mM sodium chloride (pH 4) to remove cell-bound IL-2, as described in detail in Zambello et al. (1990) . The following MAbs were used: anti-CD25 (anti-Tac) MAb, which recognises the p55 IL-2R and blocks IL-2 binding to this subunit, was a gift from T. Uchiyama (Kyoto, Japan) (Uchiyama et al., 1981) ; TU27 MAb was a gift from K. Sugamura (Senday, Japan) and J. Hamuro (Kawasaki, Japan); it recognises the p75 chain of IL-2R. Controls for flow cytometry analysis were performed using isotype control antibodies. The expression of IL-2 receptors on TILs was also investigated by evaluating the binding of phycoerythrin-conjugated IL-2 (PE-IL-2, R & D Systems, Minneapolis) on the cell surface using a flow cytometer. Briefly, 10 gil of PE-IL-2 (10 ig ml-') was added to 106 cells and the mixture was incubated on ice for 60 min. Cells were then washed twice and resuspended in 0.2 ml of PBS for flow cytometric analysis. As control for the FACS analysis, cells were incubated with a control IgG and avidin PE. The lymphocytes were analysed as indicated below. Blocking experiments were carried out by pretreating the cells for 1 h at 4°C with the following antibodies: 20gig ml-' anti-CD25 and 100 gig ml ' TU27 for IL-2 binding. After washing, the cells were incubated with PE-IL-2, as reported above. In this case, the control tube contained IgGl MAb and PE-streptavidin. Ten thousand cells bearing the typical lymphocyte scatter were scored.
Culture conditions TIL lines and freshly isolated TILs were cultured in 96 round-bottom well plates (Titretek) in RPMI-1640 medium supplemented with 10% FCS (ICN), penicillin (50 U ml-') and streptomycin (50 fig ml-' ). Cultures were carried out in triplicate, with each well containing 1 x 105 cells in 0.2 ml of medium, and were incubated for 2 days at 37°C in a humidified atmosphere of 5% carbon dioxide and 95% air. Recombinant IL-2 was added at the beginning of the culture at different concentrations (1, 10, 100, 1,000 U ml-'). In order to block the IL-2-induced effects, the cells were cultured for 30 min with anti- Tac 
Results
Evaluation of mRNA transcripts for IL-2 receptors To assess the presence of specific mRNA for IL-2 receptors, Northern blot analysis was performed on six TIL lines. As shown in Figure 1 , all TIL lines tested contained detectable amounts of p75 mRNA with a size of 4.0 kb. When the same Northern blot was hybridised with a specific probe for the p55 IL-2R, p55 mRNA of 3.5 and 1.5 kb was also detected in all lines. The amount of RNA loaded on the gel is represented by the constitutionally expressed actin mRNA of 2.1 kb and is reported at the bottom of the figure.
Binding of anti-IL-2R antibodies and PE-IL-2 to TILs
Flow cytometric analysis showed that both IL-2R subunits (p55 and p75 chains) were expressed on TIL lines to varying degrees (p55 IL-2R, 35% ± 8.6; p75 IL-2R, 66% ± 9.3). The pattern of expression of different receptors in two representative TIL lines is reported in Figure 2 . When the histograms of TILs stained with anti-p55 and anti-p75 IL-2R MAbs (Figure 2a and b) were superimposed on the control IgG histogram, a shift of the two histograms was observed with respect to the control, thus indicating that the entire population of TILs expresses both the p75 and p55 IL-2R, although to different degrees of density. Blocking experiments of PE-IL-2 binding with anti-p55 and anti-p75 IL-2R MAbs were also performed. TILs were treated with these antibodies either individually or in combination, stained with PE-IL-2 and then analysed by flow cytometry. As illustrated in Figure  2c and d, anti-p55 IL-2R MAb affected the binding of PE-IL-2 to TILs. A low blocking effect of PE-IL-2 binding was also observed in the presence of anti-p75 IL-2R MAb.
The analysis of IL-2 receptors on freshly isolated TILs demonstrated that freshly isolated TILs express both subunits to a lesser extent (data not shown).
To verify whether some T-cell subsets preferentially bear the IL-2 receptors, a two-colour analysis was performed using CD4, CD8 and antil-IL-2R MAbs. The flow cytometric analysis related to one representative TIL line demonstrated that both CD4+ and CD8+ cells expressed p55 and p75 IL-2 receptors (Figure 3) , and results in other cases were consistent with this finding. Effects of anti-IL-2R antibodies on in vitro TIL growth Since anti-p55 IL-2R and anti-p75 IL-2R MAbs have been shown to bind to TILs, and in order to determine whether these antibodies affect the biological effects induced by IL-2, TILs were cultured with different IL-2 concentrations (1, 10, 100, 1,000 U ml-') in the presence or absence of anti-IL-2R
MAbs. Figure 4 shows the mean ± s.d. of 3H-TdR uptake by 12 TIL lines at different IL-2 concentrations. TILs proliferated at both low and high IL-2 concentrations, and these data are consistent with the phenotypic findings that these cells are equipped with a high-affinity IL-2R complex. When TIL lines were cultured in the presence of different concentrations of IL-2 and anti-IL-2R MAbs (anti-Tac and TU27 MAbs) (Figure 4) , a variable inhibitory effect was observed when each antibody was individually added to the assay. When both MAbs were simultaneously added, a complete block of the IL-2-driven proliferation was observed.
Freshly isolated TILs obtained from four patients were cultured in the same experimental conditions. The results obtained in one representative subject are reported in Figure  5 . TILs proliferated to low and high concentrations of IL-2 in a way similar to that observed in TIL lines. A variable inhibitory effect was observed following incubation with anti-IL-2R MAbs; the proliferation was completely blocked by the combination of the two MAbs.
Discussion
The data provided herein demonstrate that TILs express both the p55 and p75 IL-2R subunits and that these structures deliver a proliferative signal to TILS. In fact, blocking these receptors resulted in an inhibition of TIL proliferation induced by The observations that TILs from patients with solid tumours express both anti-p55 and anti-p75 IL-2R chains and that specific antibodies inhibit the binding of PE-IL-2 (Hatakeyama et al., 1989b; Minamoto et al., 1990; Tsudo et al., 1990 (Voss et al., 1990) and by the finding that another molecule of nearly 64 kDa is likely to represent a prerequisite for the binding of IL-2 to the p75 IL-2R (Takeshita et al., 1992) .
The experiments reported in Figure 4 were designed to investigate the functional property of these IL-2R molecules on TIL lines. Our observation that TILs proliferate at low, intermediate and high IL-2 concentrations and the demonstration that anti-IL-2R MAbs (both anti-p55 and anti-p75 IL-2R) inhibit the IL-2-driven TIL proliferation suggest that a complete and fully functional IL-2 receptor structure is expressed on TILs grown in vitro. Whether this receptor apparatus has some clinical relevance in vivo still remains to be defined. In this regard, the fact that freshly isolated TILs from four patients were also observed to proliferate in response to IL-2 and the demonstration that the proliferative signal is inhibited by MAbs specifically recognising IL-2 receptors prompts us to speculate that in vivo IL-2 could preferentially trigger infiltration into the tumour of lymphocytes which are equipped with a high-affinity IL-2R. The triggering of this molecule might result in a cascade of events (i.e. release of cytotoxic factors, cytokines, etc.) which are involved in the control of tumour growth in the microenvironment where the neoplasia occurs.
Since we provided evidence that both IL-2Rs are expressed on TILs, the possibility that these receptors are preferentially expressed on one particular cell subset rather than on another was ruled out by the analysis of the coexpression of these structures on CD4 and CD8 subsets. The lack of any preferential expression of IL-2R on different T-cell subsets indicates that both CD4 + and CD8 + TILs are characterised by the same receptor structure and suggests that the IL-2-induced TIL proliferation does not select any discrete cell subset, at least in terms of expression of CD4 and CD8 molecules.
The possibility that IL-2 receptors might transduce other functional signals, i.e. the release of cytotoxic factors and other cytokines which might be involved in the control of tumour growth and/or outgrowth of TILs themselves, underlines the variety of immunoregulatory activities mediated by these molecules. In this regard tumour necrosis factor a (TNF-a), a cytokine that is released by TIL following autologous tumour stimulation (Schwartzentruber et al., 1991) and following stimulation with IL-2 (Belldegrun et al., 1989; Wang et al., 1989; Vaccarello et al., 1990; loannides et al., 1992) , might exhibit pleiotropic activites on both TILs and tumour cells. Studies are in progress to verify this hypothesis. The authors wish to thank the Biogen Corp. (Cambridge, MA, USA) for supplying recombinant IL-2; Dr K. Sugamura (Senday, Japan) and Dr J. Hamuro (Kawasaki, Japan) for providing TU27 MAb; Dr T. Uchiyama (Kyoto, Japan) for providing anti-Tac MAb; Dr M. Hatakeyama (Osaka, Japan) for kindly providing the p75 IL-2R cDNA probe; Dr I. Stamenkovic (Charlestown, MA, USA) for providing p55 IL-2R cDNA probe and Mrs Denise Kilmartin for her help in the preparation of the manuscript. Bulian is a recipient of a fellowship from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan).
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